We haveenough cashto go wellinto 2023We will openupinternationalsites forMino-Lok trialI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We willhaveexclusivityI/ONTAKwas thebest deal Iever madeMino-WrapAn actualiMSCupdateInsidersinvested$26.5mI/ONTAK'spotentialmarket is>$300mThere are noFDAapproveddrugs to treathemorrhoidsOur Halo-Lido trial willhave finalpatient byend of 2022The name Citiuscomes from theOlympic motto"Citius,AltiusForius"We expect tofinish theMino-Loktrial this yearWe had aphase 2btrial with100%efficacyI won't diluteshareholdersI'm ashareholdermyselfOnly biotechwith 2 Myron'son theleadershipteamI/ONTAKis our leadassetMyron Holubiakand I founded aprivatecompany in2013Mino-Lokpotentialmarket>$1BNot manycompaniesthis size with2 late stageassetsMino-Lokis our leadassetHemorrhoidsis a $2BmarketWe intendto submita BLA in2H 2022We haveenough cashto go wellinto 2023We will openupinternationalsites forMino-Lok trialI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We willhaveexclusivityI/ONTAKwas thebest deal Iever madeMino-WrapAn actualiMSCupdateInsidersinvested$26.5mI/ONTAK'spotentialmarket is>$300mThere are noFDAapproveddrugs to treathemorrhoidsOur Halo-Lido trial willhave finalpatient byend of 2022The name Citiuscomes from theOlympic motto"Citius,AltiusForius"We expect tofinish theMino-Loktrial this yearWe had aphase 2btrial with100%efficacyI won't diluteshareholdersI'm ashareholdermyselfOnly biotechwith 2 Myron'son theleadershipteamI/ONTAKis our leadassetMyron Holubiakand I founded aprivatecompany in2013Mino-Lokpotentialmarket>$1BNot manycompaniesthis size with2 late stageassetsMino-Lokis our leadassetHemorrhoidsis a $2BmarketWe intendto submita BLA in2H 2022

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. We have enough cash to go well into 2023
  2. We will open up international sites for Mino-Lok trial
  3. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  4. We will have exclusivity
  5. I/ONTAK was the best deal I ever made
  6. Mino-Wrap
  7. An actual iMSC update
  8. Insiders invested $26.5m
  9. I/ONTAK's potential market is >$300m
  10. There are no FDA approved drugs to treat hemorrhoids
  11. Our Halo-Lido trial will have final patient by end of 2022
  12. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  13. We expect to finish the Mino-Lok trial this year
  14. We had a phase 2b trial with 100% efficacy
  15. I won't dilute shareholders
  16. I'm a shareholder myself
  17. Only biotech with 2 Myron's on the leadership team
  18. I/ONTAK is our lead asset
  19. Myron Holubiak and I founded a private company in 2013
  20. Mino-Lok potential market >$1B
  21. Not many companies this size with 2 late stage assets
  22. Mino-Lok is our lead asset
  23. Hemorrhoids is a $2B market
  24. We intend to submit a BLA in 2H 2022